Skip to NavigationSkip to content

News

AbbVie have released that two Phase 3 trials of its experimental cancer drug, veliparib, missed both of their primary endpoints.
A team of scientists have identified methods to prevent neurodegeneration in mice, leading to new hopes in the treatment of diseases such as...
Alpine Immune Sciences has agreed a deal to merge with Nivalis Therapeutics, in an all-stock deal. The deal will create a biotech with cash $90...
An investigational drug from ImmunoGen could prove effective in treating platinum-resistant ovarian cancer, an area of significant unmet need with...
‘World Hemophilia Day’ occurred on 17 April and the day was marked by the release of data from two companies involved in treating the condition.
Researchers have developed a prognostic tool which they claim can accurately predict the risk of kidney failure in both types of diabetes.
A new study has suggested that cannabidiol, a molecule derived from cannabis without its psychoactive effects, can prove beneficial for some...
Researchers from Emory University in Atlanta, in collaboration with researchers from the Rajiv Gandhi Center for Biotechnology in India, discovered...
A new study has suggested that dementia patients may not require as high a dosage of antipsychotic medication that was once thought.
Pfizer has announced the launch of ‘Pfizer Healthcare Hub: London’, a project that aims to help startups, focusing on the development of technology...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches